Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0545
+0.0045 (9.00%)
Apr 24, 2025, 3:55 PM EDT

YBGJ Statistics

Total Valuation

YBGJ has a market cap or net worth of 6.05 million. The enterprise value is 6.86 million.

Market Cap 6.05M
Enterprise Value 6.86M

Important Dates

The last earnings date was Friday, April 11, 2025.

Earnings Date Apr 11, 2025
Ex-Dividend Date n/a

Share Statistics

YBGJ has 119.82 million shares outstanding. The number of shares has increased by 900.00% in one year.

Current Share Class n/a
Shares Outstanding 119.82M
Shares Change (YoY) +900.00%
Shares Change (QoQ) n/a
Owned by Insiders (%) 53.64%
Owned by Institutions (%) n/a
Float 14.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,743.10
PB Ratio -1.83
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.86
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.14

Current Ratio 0.14
Quick Ratio 0.10
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -77.36%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 62.19%
Revenue Per Employee 193
Profits Per Employee -98,628
Employee Count 18
Asset Turnover 0.00
Inventory Turnover 1.69

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.26% in the last 52 weeks. The beta is 1.12, so YBGJ's price volatility has been higher than the market average.

Beta (5Y) 1.12
52-Week Price Change -94.26%
50-Day Moving Average 0.06
200-Day Moving Average 0.10
Relative Strength Index (RSI) 50.52
Average Volume (20 Days) 6,150

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.13

Income Statement

In the last 12 months, YBGJ had revenue of 3,470 and -1.78 million in losses. Loss per share was -0.01.

Revenue 3,470
Gross Profit -209,275
Operating Income -1.98M
Pretax Income -1.98M
Net Income -1.78M
EBITDA -1.80M
EBIT -1.98M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 7,015 in cash and 692,686 in debt, giving a net cash position of -685,671 or -0.01 per share.

Cash & Cash Equivalents 7,015
Total Debt 692,686
Net Cash -685,671
Net Cash Per Share -0.01
Equity (Book Value) -3.30M
Book Value Per Share -0.03
Working Capital -4.04M
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.34M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -57,113.60%
Pretax Margin -57,112.16%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

YBGJ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -900.00%
Shareholder Yield -900.00%
Earnings Yield -29.35%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

YBGJ has an Altman Z-Score of -7.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.56
Piotroski F-Score n/a